agilon health Inc (AGL)

Currency in USD
84.56
-2.28(-2.63%)
Closed·
84.560.00(0.00%)
·
Advertisement
AGL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
82.9786.66
52 wk Range
7.48133.04
Key Statistics
Prev. Close
84.56
Open
86.66
Day's Range
82.97-86.66
52 wk Range
7.48-133.04
Volume
211.91K
Average Volume (3m)
309.19K
1-Year Change
194.1217%
Book Value / Share
13.64
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AGL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
118.08
Upside
+39.64%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

agilon health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

5 Buy
10 Hold
1 Sell
Ratings:
16 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 118.08
(+39.64% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Bernstein SocGen Group
Buy125.00+47.82%86.00Upgrade15/09/2026
Truist Securities
Hold112.00+32.45%-Maintain24/08/2026
JPMorgan
Sell85.00+0.52%31.00Maintain24/08/2026
Wells Fargo
Buy146.00+72.66%141.00Maintain11/08/2026
Citi
Hold115.00+36.00%105.00Upgrade10/08/2026

agilon health Inc SWOT Analysis


Profitability Push
Agilon Health pivots from rapid growth to profitability amid challenging financial results, including revenue decline and EBITDA losses in Q2 2025
Leadership Transition
CEO departure triggers strategic reevaluation, with focus shifting to operational efficiency and improved financial performance under interim leadership
Market Headwinds
Explore how medical cost pressures, declining membership, and cash burn impact Agilon's path to positive cash flow, projected for 2027
Analyst Outlook
Price targets range from $2 to $3, reflecting cautious market sentiment as Agilon navigates profitability challenges in the Medicare Advantage secto
Read full SWOT analysis

agilon health Inc Earnings Call Summary for Q2/2026

  • Agilon Health reported Q2 2026 EPS of $1.04, beating estimates by $0.96, with revenue of $1.49B topping forecasts by $50M amid 7.1% YoY growth.
  • Medical margin surged to $197M from negative $53M YoY; adjusted EBITDA reached $70M versus negative $83M, driven by risk adjustment and cost improvements.
  • Company raised FY2026 guidance to ~$5.8B revenue, ~$485M medical margin, and ~$85M adjusted EBITDA despite intentional 12.3% membership decline.
  • Shares jumped 13.79% to $107.85, adding 1.92% after-hours; stock has gained 500% over six months as strategic contracting discipline improves profitability.
  • Management expects 7% medical cost trends in H2 2026, with risk adjustment benefits continuing into 2027 though at lower levels than current year.
Last Updated: 05/08/2026, 22:40
Read Full Transcript

Earnings

Latest Release
05/08/2026
EPS / Forecast
1.04 / 0.08
Revenue / Forecast
1.49B / 1.44B
EPS Revisions
Last 90 days

Compare AGL to Peers and Sector

Metrics to compare
AGL
Peers
Sector
Relationship
P/E Ratio
−5.7x8.3x−0.4x
PEG Ratio
−0.210.140.00
Price/Book
6.2x2.7x2.6x
Price / LTM Sales
0.2x0.8x3.1x
Upside (Analyst Target)
39.6%43.6%55.6%
Fair Value Upside
Unlock21.2%7.8%Unlock

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.00M23.36%338.43M
Other Institutional Investors
13.57M76.64%1.15B
Public Companies & Retail Investors
0.000.00%0.00
Total
17.57M100.00%1.49B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Clayton, Dubilier & Rice, LLC23.82%4,000,000338,240
Morgan Stanley Investment Management Inc.11.71%1,966,470166,285

People Also Watch

20.740
OMER
-1.47%
154.26
CFR
-1.21%
102.12
MZTI
-1.39%
16.75
SBH
-1.24%
23.82
NVST
-1.49%

FAQ

What Is the agilon health (NYSE: AGL) Share Price Today?

The agilon health stock price today is 84.56 USD.

What Stock Exchange Does agilon health (AGL) Trade On?

agilon health is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for agilon health?

The stock symbol (also called a 'ticker') for agilon health is "AGL."

What Is the Current agilon health Market Capitalisation?

As of today, agilon health (NYSE: AGL) market cap is 1.42B USD.

What Is agilon health's (AGL) Earnings Per Share (TTM)?

The agilon health EPS is currently -15.12 (Trailing Twelve Months).

When Is the Next agilon health Earnings Date?

agilon health's next earnings report will be released on 29/10/2026.

Is AGL a Buy or Sell From a Technical Analyst Perspective?

Based on today's agilon health moving averages and other technical indicators, the daily buy/sell signal for AGL stock is Strong Sell.

How Many Times Has agilon health Stock Split?

agilon health has split 1 times. (See the AGL stock split history page for full effective split date and price information.)

How Many Employees Does agilon health Have?

agilon health has 856 employees, based on their latest Companies House report.

What is the current trading status of agilon health (NYSE: AGL)?

As of 24/09/2026, agilon health (AGL) is trading at a share price of 84.56 USD, with a previous close of 84.56 USD. The stock has fluctuated within a day range of 82.97 USD to 86.66 USD, while its 52-week range spans from 7.48 USD to 133.04 USD.

What Is agilon health (AGL) Price Target According to Analysts?

The average 12-month price target for agilon health is 118.08 USD, with a high estimate of 146 USD and a low estimate of 85 USD. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +39.64% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.